The growth of deadly plaque inside the walls of arteries may not happen as scientists believed, research from the University of Toronto and Massachusetts General Hospital has found.
The research also suggests a new potential target in the treatment of atherosclerosis, a leading cause of cardiovascular disease and death globally.
The research team found that macrophages, white blood cells that drive atherosclerosis, replicate inside plaques. Moreover, this growth is not reliant on cells outside the plaques called monocytes, as scientists had assumed.
“Until now, the thinking was that inflammatory macrophages arise mainly from the recruitment of their precursors — monocytes — from the bloodstream,” said Clint Robbins, lead author on the study and an Assistant Professor in U of T’s Departments of Laboratory Medicine and Pathobiology, and Immunology. “Our study shows that the accumulation of macrophages also depends on their proliferation locally within the developing plaque.”
The journal Nature Medicine published the study results today.
The impact of the research on clinical treatments could be large. Many pharmaceutical companies are pouring resources into potential therapies that can block the recruitment of white blood cells into plaques. But if macrophages self-sustain through local cell division, blocking recruitment may not be the best strategy.
“I think this work will force some major re-evaluations,” said Filip Swirski, the study’s principal investigator who is a scientist in the Center for Systems Biology at Massachusetts General Hospital and an Assistant Professor at Harvard Medical School. “People have been thinking of targeting monocyte influx to treat atherosclerosis, but they need to consider macrophage proliferation as an additional or alternative approach, especially in established disease.”
That approach might be better than targeting circulating monocytes, since interrupting disease-causing processes within plaques could spare other beneficial immune responses that monocytes control, said Swirski.
As well, it could help improve the current standard of care in treating atherosclerosis: statin therapy. Statins, in addition to lowering blood lipids that contribute to plaque, have anti-inflammatory properties. The researchers are now looking at whether statins might limit the spread of macrophages within plaques.
“Additional targeting of macrophage proliferation may further decrease inflammation in atherosclerosis and prove clinically advantageous,” said Robbins, who is also a scientist in the Toronto General Research Institute at University Health Network.
The researchers conducted their study in mice, and they caution that much more research is needed to see how the work will translate to humans. But encouragingly, they found evidence of macrophage growth in plaques from human carotid arteries.
The Latest on: Heart disease
- Two Twin Cities women become ‘heart sisters’ after transplants on February 9, 2019 at 6:54 pm
... established the Go Red for Women campaign 15 years ago to raise awareness that one in three women are impacted by heart disease. Both women and doctors need to be more aware that it can affect wom... […]
- A blueprint to rebuild your heart on February 9, 2019 at 5:54 pm
You’ll learn more about a heart-healthy lifestyle that includes diet, exercise and stress reduction so you can continue to improve your health on your own. Survey data published in the Morbidity and M... […]
- Community News: NorthBay Healthcare to host heart disease Facebook chat on February 9, 2019 at 2:44 pm
FAIRFIELD — Heart disease is the leading cause of death in the United States, claiming the lives of more than 600,000 people every year. In an effort to help educate the public on how to recognize the ... […]
- Rome Run & Indoor Walk raises $17,000 to fight heart disease on February 9, 2019 at 2:31 pm
ROME, N.Y. — Hundreds of walkers and runners joined the American Heart Association to be a relentless force for a world of longer, healthier lives at the Rome Run & Indoor Walk. Walkers and runners ra... […]
- Heart disease: Know the signs, start a conversation on February 9, 2019 at 12:05 pm
February is American Heart Month. You may have seen someone wearing red or maybe you even donned red yourself on Feb. 1 as part of the American Heart Association’s National Wear Red Day and Go Red for ... […]
- Running and walking in Rome to fight heart disease and stroke on February 9, 2019 at 9:14 am
Rome, N.Y. - The track inside Rome Free Academy was fill with runners and walkers Saturday morning and their goal was to not only get healthy, but to help keep others healthy. The 17th annual Rome Run ... […]
- NewYork-Presbyterian Queens helping women fight heart disease on February 8, 2019 at 10:50 pm
NewYork-Presbyterian Queens Hospital is helping women in the fight against heart disease. The Flushing medical center’s cardiologists work to prevent the disease for the women of Queens in multiple wa... […]
- How women can reduce risk of heart disease on February 8, 2019 at 3:16 pm
In honor of American Heart Month, Kathie Lee and Hoda share one mom-to-be’s story about how her pregnancy led to her heart disease diagnosis. Then, Dr. Jennifer Mieres, a cardiologist, shares ways to ... […]
- MRI cardiac stress test shows promise at identifying fatal heart disease on February 8, 2019 at 10:57 am
The use of MRI to determine heart function has been slow to catch on, but a study from Duke Health researchers shows that stress cardiac MRI not only diagnoses disease, but can also predict which ... […]
- Study ties cancer-causing HPV to heart disease, too on February 7, 2019 at 11:33 am
(HealthDay)—Certain strains of HPV are known to cause cervical cancer and other types of tumors. Now, a new study raises the possibility that they might also contribute to heart disease. […]
via Google News and Bing News